• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

免疫介导性肾小球肾炎中的表位扩展:不断扩大的靶标。

Epitope Spreading in Immune-Mediated Glomerulonephritis: The Expanding Target.

机构信息

Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, 00168 Rome, Italy.

Nephrology, Dialysis and Transplantation Unit, Fondazione Policlinico Universitario A. Gemelli IRCCS, 00168 Rome, Italy.

出版信息

Int J Mol Sci. 2024 Oct 16;25(20):11096. doi: 10.3390/ijms252011096.

DOI:10.3390/ijms252011096
PMID:39456878
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11507388/
Abstract

Epitope spreading is a critical mechanism driving the progression of autoimmune glomerulonephritis. This phenomenon, where immune responses broaden from a single epitope to encompass additional targets, contributes to the complexity and severity of diseases such as membranous nephropathy (MN), lupus nephritis (LN), and ANCA-associated vasculitis (AAV). In MN, intramolecular spreading within the phospholipase A2 receptor correlates with a worse prognosis, while LN exemplifies both intra- and intermolecular spreading, exacerbating renal involvement. Similarly, ANCA reactivity in AAV highlights the destructive potential of epitope diversification. Understanding these immunological cascades reveals therapeutic opportunities-targeting early epitope spreading could curb disease progression. Despite promising insights, the clinical utility of epitope spreading as a prognostic tool remains debated. This review provides a complete overview of the current evidence, exploring the dual-edged nature of epitope spreading, the intricate immune mechanisms behind it, and its therapeutic implications. By elucidating these dynamics, we aim to pave the way for more precise, targeted interventions in autoimmune glomerular diseases.

摘要

表位扩展是驱动自身免疫性肾小球肾炎进展的关键机制。这种免疫反应从单一表位扩展到包含更多靶标的现象,导致了膜性肾病(MN)、狼疮性肾炎(LN)和抗中性粒细胞胞质抗体相关性血管炎(AAV)等疾病的复杂性和严重性。在 MN 中,磷脂酶 A2 受体内部的分子内扩展与预后不良相关,而 LN 则同时体现了分子内和分子间的扩展,加重了肾脏受累。同样,AAV 中的 ANC 反应突出了表位多样化的破坏性潜力。了解这些免疫级联反应揭示了治疗机会——靶向早期表位扩展可能会抑制疾病进展。尽管有很有前景的见解,但表位扩展作为一种预后工具的临床实用性仍存在争议。本综述提供了当前证据的全面概述,探讨了表位扩展的双重性质、其背后复杂的免疫机制及其治疗意义。通过阐明这些动态,我们旨在为自身免疫性肾小球疾病的更精确、靶向干预铺平道路。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b1/11507388/9c02c511ef91/ijms-25-11096-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b1/11507388/7f13b436f65e/ijms-25-11096-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b1/11507388/9c02c511ef91/ijms-25-11096-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b1/11507388/7f13b436f65e/ijms-25-11096-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/82b1/11507388/9c02c511ef91/ijms-25-11096-g003.jpg

相似文献

1
Epitope Spreading in Immune-Mediated Glomerulonephritis: The Expanding Target.免疫介导性肾小球肾炎中的表位扩展:不断扩大的靶标。
Int J Mol Sci. 2024 Oct 16;25(20):11096. doi: 10.3390/ijms252011096.
2
Epitope Spreading of Autoantibody Response to PLA2R Associates with Poor Prognosis in Membranous Nephropathy.抗磷脂酶A2受体自身抗体反应的表位扩展与膜性肾病的不良预后相关。
J Am Soc Nephrol. 2016 May;27(5):1517-33. doi: 10.1681/ASN.2014111061. Epub 2015 Nov 13.
3
Editorial: Immune Monitoring Responses in Renal Autoimmune Diseases.社论:肾脏自身免疫性疾病中的免疫监测反应
Front Immunol. 2021 Jun 29;12:722791. doi: 10.3389/fimmu.2021.722791. eCollection 2021.
4
Rare case of exostosin 1/exostosin 2-related membranous lupus nephritis concomitant with dual ANCA- and anti-GBM antibody-associated crescentic glomerulonephritis effectively diagnosed by mass spectrometry: a case report.罕见的外显子 1/外显子 2 相关膜性狼疮肾炎合并双重 ANCA 和抗 GBM 抗体相关新月体性肾小球肾炎通过质谱法有效诊断:一例报告。
BMC Nephrol. 2023 Jul 24;24(1):218. doi: 10.1186/s12882-023-03268-1.
5
Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.髓过氧化物酶抗中性粒细胞胞浆抗体通过免疫复合物形成和寡免疫机制导致不同的肾脏疾病:一例报告。
Pathol Int. 2017 Aug;67(8):419-424. doi: 10.1111/pin.12545. Epub 2017 Jun 4.
6
Angiotensin II Type 2 Receptor Antibodies in Glomerular Diseases.血管紧张素 II 型受体抗体在肾小球疾病中的作用。
Arch Immunol Ther Exp (Warsz). 2024 Aug 19;72(1). doi: 10.2478/aite-2024-0017. eCollection 2024 Jan 1.
7
The dominant humoral epitope in phospholipase A2 receptor-1: presentation matters when serving up a slice of π.磷脂酶A2受体-1中的主要体液表位:当提供一片π时,呈现方式很重要。
J Am Soc Nephrol. 2015 Feb;26(2):237-9. doi: 10.1681/ASN.2014090877. Epub 2014 Oct 6.
8
Idiopathic membranous nephropathy: an autoimmune disease.特发性膜性肾病:一种自身免疫性疾病。
Semin Nephrol. 2011 Jul;31(4):333-40. doi: 10.1016/j.semnephrol.2011.06.004.
9
Clinical Relevance of Domain-Specific Phospholipase A Receptor 1 Antibody Levels in Patients with Membranous Nephropathy.膜性肾病患者特异性磷脂酶 A 受体 1 抗体水平的临床意义。
J Am Soc Nephrol. 2020 Jan;31(1):197-207. doi: 10.1681/ASN.2019030273. Epub 2019 Dec 16.
10
Identification of the immunodominant epitope region in phospholipase A2 receptor-mediating autoantibody binding in idiopathic membranous nephropathy.鉴定特发性膜性肾病中磷脂酶A2受体介导自身抗体结合的免疫显性表位区域。
J Am Soc Nephrol. 2015 Feb;26(2):291-301. doi: 10.1681/ASN.2013121315. Epub 2014 Sep 9.

引用本文的文献

1
The Complex Role of Gut Microbiota in Systemic Lupus Erythematosus and Lupus Nephritis: From Pathogenetic Factor to Therapeutic Target.肠道微生物群在系统性红斑狼疮和狼疮性肾炎中的复杂作用:从致病因素到治疗靶点
Microorganisms. 2025 Feb 18;13(2):445. doi: 10.3390/microorganisms13020445.

本文引用的文献

1
Obinutuzumab in Refractory Membranous Nephropathy: A Case Series.奥妥珠单抗治疗难治性膜性肾病:病例系列
Kidney Med. 2024 Jun 18;6(8):100853. doi: 10.1016/j.xkme.2024.100853. eCollection 2024 Aug.
2
Pathogenesis of IgA nephropathy as a tissue-specific autoimmune disease.IgA肾病作为一种组织特异性自身免疫性疾病的发病机制。
Int Immunol. 2024 Dec 26;37(2):75-81. doi: 10.1093/intimm/dxae047.
3
Predictive value of the domain specific PLA2R antibodies for clinical remission in patients with primary membranous nephropathy: A retrospective study.
原发性膜性肾病患者 PLA2R 抗体的预测价值:一项回顾性研究。
PLoS One. 2024 May 8;19(5):e0302100. doi: 10.1371/journal.pone.0302100. eCollection 2024.
4
Quantitative detection and prognostic value of antibodies against M-type phospholipase A2 receptor and its cysteine-rich ricin domain and C-type lectin domains 1 and 6-7-8 in patients with idiopathic membranous nephropathy.特发性膜性肾病患者抗 M 型磷脂酶 A2 受体及其富含半胱氨酸的蓖麻毒素域和 C 型凝集素域 1、6-7-8 抗体的定量检测及其预后价值。
PLoS One. 2024 Feb 22;19(2):e0298269. doi: 10.1371/journal.pone.0298269. eCollection 2024.
5
Lupus-like membranous nephropathy during the postpartum period expressing glomerular antigens exostosin 1/exostosin 2 and phospholipase A2 receptor: a case report.产后期表达外显子素 1/外显子素 2 和磷脂酶 A2 受体的狼疮样膜性肾病:一例报告。
CEN Case Rep. 2024 Oct;13(5):318-325. doi: 10.1007/s13730-023-00848-w. Epub 2024 Jan 27.
6
KDIGO 2024 Clinical Practice Guideline for the management of LUPUS NEPHRITIS.KDIGO 2024狼疮性肾炎管理临床实践指南。
Kidney Int. 2024 Jan;105(1S):S1-S69. doi: 10.1016/j.kint.2023.09.002.
7
Anti-Phospholipase A2 Receptor 1 and Anti-Cysteine Rich Antibodies, Domain Recognition and Rituximab Efficacy in Membranous Nephropathy: A Prospective Cohort Study.抗磷脂酶 A2 受体 1 抗体和抗胱氨酸丰富域抗体在膜性肾病中的识别作用及利妥昔单抗疗效:一项前瞻性队列研究。
Am J Kidney Dis. 2024 May;83(5):588-600.e1. doi: 10.1053/j.ajkd.2023.10.013. Epub 2023 Dec 25.
8
Tertiary lymphoid structures as local perpetuators of organ-specific immune injury: implication for lupus nephritis.三级淋巴结构作为器官特异性免疫损伤的局部持续因素:对狼疮肾炎的影响。
Front Immunol. 2023 Oct 31;14:1204777. doi: 10.3389/fimmu.2023.1204777. eCollection 2023.
9
A Phase 2 Trial of Sibeprenlimab in Patients with IgA Nephropathy.Sibeprenlimab 治疗 IgA 肾病患者的 II 期临床试验。
N Engl J Med. 2024 Jan 4;390(1):20-31. doi: 10.1056/NEJMoa2305635. Epub 2023 Nov 2.
10
Mayo Clinic Consensus Report on Membranous Nephropathy: Proposal for a Novel Classification.Mayo 诊所膜性肾病共识报告:新型分类建议。
Mayo Clin Proc. 2023 Nov;98(11):1671-1684. doi: 10.1016/j.mayocp.2023.08.006. Epub 2023 Oct 5.